DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...
Dr. Victor Velculescu, CEO and founder of Delfi Diagnostics. Baltimore life sciences company Delfi Diagnostics is $225 million closer to bringing its blood test for early detection of cancer to the ...
The Hackensack Meridian Hennessy Institute for Cancer Prevention and Applied Molecular Medicine announced a partnership with ...
BALTIMORE and PALO ALTO, Calif., Dec. 2, 2024 /PRNewswire/ -- Today, DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer ...
BALTIMORE, March 31, 2021 /PRNewswire/ --Delfi Diagnostics, Inc., a pioneering developer of next generation high performance, affordable liquid biopsy tests for early cancer detection, announced the ...
Provider of Accessible Blood-Based Tests for Cancer Detection Highlights Results of Clinical Trial in Preeminent Peer-Reviewed Publication The company currently has an active pipeline of biotech and ...
DELFI Diagnostics has clinically validated FirstLook Lung, its blood test designed to improve early detection of lung cancer, which remains the leading cause of cancer deaths in the United States. At ...
DFJ Growth's Justin Kao Joins Delfi Board of Directors BALTIMORE and PALO ALTO, Calif., July 18, 2022 /PRNewswire/ -- Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance ...
BALTIMORE, June 22, 2022 /PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection and monitoring, ...
Delfi Diagnostics, a Baltimore company developing a blood test for early detection of cancer, said it raised $100 million in funding, and is seeking to grow a team of cancer researchers and ...
DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible, and deliver a new way to help detect cancer. DELFI tests are built to solve the highest-burden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback